Advanced search×

Sex hormones and vascular protection in pulmonary arterial hypertension.

Helen A HA Christou and Raouf A RA Khalil

J Cardiovasc Pharmacol 56(5):471-4 (2010) PMID 20881609

DOI: 10.1097/FJC.0b013e3181fa8e20
Version: za2963e q8zac q8zb4 q8zc4 q8zd6 q8ze3 q8zf1 q8zgb
View PDF

Similar articles you may find interesting…

  1. The quest for full text: an in-depth examination of Pubget for medical searchers.
    Robin Featherstone and Denise Hersey

    Med Ref Serv Q 29(4):307-19 (2010) PMID 21058175

    This article examines Pubget, a free Web-based search engine for life sciences researchers for conducting searches of the medical literature and retrieving full-text PDFs. Its search functionality and add-on features are evaluated to determine potential for library instruction and pr...
  2. Influence of different degrees of liver impairment on the pharmacokinetics of clazosentan.
    Shirin S Bruderer, Victor V Detishin, ... Jasper J Dingemanse

    Br J Clin Pharmacol 71(1):52-60 (2011) PMID 21143501

    WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • Clazosentan is a selective endothelin A receptor antagonist, formulated for parenteral use, which is in clinical development for the treatment of aneurysmal subarachnoid haemorrhage. • The human ADME study showed that most of clazosentan is excreted...
    View PDF
  3. Differential effects of the dual orexin receptor antagonist almorexant and the GABA(A)-α1 receptor modulator zolpidem, alone or combined wit...
    Michel A MA Steiner, Hugues H Lecourt, ... François F Jenck

    Neuropsychopharmacology 36(4):848-56 (2011) PMID 21150905 PMCID PMC3055732

    We conclude that unlike zolpidem, almorexant does not interfere with forced motor performance or grip strength in the rat, nor does it further increase the sedative effects of ethanol. Our results suggest that the effect of almorexant can be immediately reversed to full alertness like under physiolo...
    View PDF